Collaborator Profiles
We collaborate with leading research institutions and biotechnology companies to boldly follow our mission. Together, we are expanding our understanding of the biology that controls human aging and devising interventions that enable people to lead longer and healthier lives.
Some of our collaborators include:
-
Since 2014, the collaboration between Calico and AbbVie has produced a number of drug development programs, with multiple assets advanced into clinical trials, including potential treatments for neurological conditions. Calico is now independently moving these clinical programs forward.
-
Since 2015, Calico and the Broad Institute of MIT and Harvard have partnered to investigate the biology and genetics of aging and pursue early-stage drug discovery. Through our collaborative work, we have made progress across a number of programs including the co-development of a novel PTPN2/N1 inhibitor now in clinical trials.
Learn more about our collaboration with the Broad Institute:
Calico and Broad Institute Extend Collaboration Adding Focus on Age-Related Neurodegeneration
Translational Science Thrives in the Calico-Broad Collaboration
-
Established in 2018, Calico’s partnership with UK Biobank has focused on the progression of major chronic diseases of mid-to-later life and enabling researchers to explore the mechanisms through which these diseases occur in people. Through a joint project between Calico, the UK Biobank, and the Chan Zuckerberg Initiative, we are analyzing tens of thousands of MRI scans and genetic data to create the world’s largest longitudinal imaging dataset to assess disease progression. All findings from his collaboration will be publicly available to support global scientific progress.
Learn more about our collaboration with the UK Biobank:
Uncovering New Signs of Aging in Blood
We welcome proposals for partnership. If you would like to collaborate with Calico, please provide us with a brief non-confidential proposal that describes the opportunity, including scientific supporting data, to busdev@calicolabs.com.